Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
Fformat: Online Erthygl Texto
Iaith:English
Cyhoeddwyd: Public Library of Science 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

Rhyngrwyd

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

Eitemau Tebyg